Biotech firm develops plant drug
An EU-funded project has brought pharmaceutical producing plants one step closer to reality, by creating Arabidopsis plants whose seeds contain high levels of a more complex antibody than has been grown before.
An EU-funded project has brought pharmaceutical producing plants one step closer to reality, by creating Arabidopsis plants whose seeds contain high levels of a more complex antibody than has been grown before.
Belgium's Flemish Interuniversity Institute for Biotechnology (VIB) developed the seeds, whose antibody closely resembles a human equivalent protecting cells against Hepatitis A.